首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   139篇
  免费   13篇
  国内免费   1篇
耳鼻咽喉   1篇
儿科学   3篇
妇产科学   1篇
基础医学   19篇
口腔科学   8篇
临床医学   25篇
内科学   18篇
皮肤病学   1篇
神经病学   2篇
特种医学   6篇
外科学   16篇
预防医学   15篇
药学   22篇
肿瘤学   16篇
  2023年   1篇
  2021年   6篇
  2020年   5篇
  2019年   6篇
  2018年   3篇
  2017年   4篇
  2016年   7篇
  2015年   5篇
  2014年   5篇
  2013年   8篇
  2012年   6篇
  2011年   3篇
  2010年   3篇
  2009年   5篇
  2007年   3篇
  2006年   1篇
  2005年   1篇
  2004年   4篇
  2003年   2篇
  2002年   5篇
  2001年   1篇
  2000年   5篇
  1999年   1篇
  1998年   3篇
  1997年   2篇
  1996年   1篇
  1994年   3篇
  1992年   3篇
  1991年   7篇
  1990年   4篇
  1989年   6篇
  1988年   6篇
  1987年   5篇
  1986年   2篇
  1985年   2篇
  1984年   2篇
  1983年   1篇
  1982年   1篇
  1981年   1篇
  1980年   1篇
  1979年   5篇
  1978年   1篇
  1977年   1篇
  1976年   1篇
  1974年   1篇
  1973年   1篇
  1969年   1篇
  1966年   1篇
  1919年   1篇
排序方式: 共有153条查询结果,搜索用时 6 毫秒
151.
The conditioned taste aversion procedure in mice was used to test for blockade of the drug stimulus of the 5-HT1A receptor agonists (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin HBr (8-OH-DPAT), 1-(4-trifluoromethyl-2-pyridinyl)-4- [4-[2-oxo-1-pyrrolidinyl]butyl]piperazine (E)-2-butenedioate (Org 13011) and the 5-HT reuptake inhibitor fluoxetine. The conditioned taste aversion induced by 8-OH-DPAT (0.22 mg/kg) and Org 13011 (0.5 mg/kg) was readily blocked by the 5-HT1A receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY-100635) (0.1 mg/kg). The conditioned taste aversion induced by fluoxetine could not be antagonized by WAY-100635 nor by the 5-HT2 receptor antagonist mianserin. It is concluded that the conditioned taste aversion induced by 8-OH-DPAT or Org 13011 is mediated via 5-HT1A receptors. The results suggest that the conditioned taste aversion induced by fluoxetine is not exclusively mediated by 5-HT1A receptors nor exclusively by 5-HT2 receptors. The results also indicate that the conditioned taste aversion paradigm can be used to test for antagonism of stimulus properties of compounds.  相似文献   
152.
153.

Objective

Hospitals in the Netherlands have recently made certain performance data public, allowing patients to choose the location of their care. The objective of this study is to assess (a) patient preferences and experiences concerning the transition between primary and secondary health care, (b) patients’ needs for choice and information and how these are influenced by personal and morbidity factors.

Methods

Two different types of questionnaires were used. The first questionnaire concerns the importance that patients attach to the care provided. The second questionnaire concerns the actual experiences of the patient with the care provided.For the selection of patients, we used the databases of the registration networks of the Departments of General Practice of the Universities of Groningen and Leiden. The questionnaires were returned by 513 patients (Importance 69%) and 1404 patients (Experience 65%).

Results

Many patients prefer the GP advising them regarding which hospital or specialist they should be referred to: a quarter of the patients preferred that the GP decided for them. Patients with a curable condition and patients aged between 25 and 65, highly educated and with stable personal characteristics as measured by a purposive scale, more often wished to use information from internet or newspapers to make a decision.The amount of information that was needed on illness or treatment varied greatly. Young people, older people, and those with less stable personal characteristics more often desired only practical information.

Conclusions

In spite of making performance data of different health care institutions public, only a limited number of patients want to use this information on a limited number of health problems.

Practice implications

Care providers should take differences into account concerning patients’ need for information on their illness.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号